{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Allegan",
      "state": "MI",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "88384",
      "recalling_firm": "Perrigo Company PLC",
      "address_1": "515 Eastern Ave",
      "address_2": "N/A",
      "postal_code": "49010-9070",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0329-2022",
      "product_description": "GoodSense Aller.Ease, Fexofenadine hydrochloride 12 HR, 60 mg tablets, 24 count bottle, UPC 3 0113 0425 62 7;  Made in the Czech Republic, Distributed by: Perrigo Allergan MI 49010.",
      "product_quantity": "36,048 containers",
      "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.",
      "recall_initiation_date": "20210727",
      "center_classification_date": "20220105",
      "termination_date": "20221108",
      "report_date": "20220112",
      "code_info": "Lot# 0JE2487 , 0KE2982, Exp 1/31/2022"
    }
  ]
}